LIGAND PHARMACEUTICALS INC
LGND
40 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | Jul 10 9:08 PM | KOZARICH JOHN W | Proposed Sale | 934 | $125.00 | $116.8K | — | View → |
| Jun 23, 2025 | Jun 23 9:07 PM | ANDREW THOMAS REARDON | Proposed Sale | 500 | $114.08 | $57.0K | — | View → |
| Jun 10, 2025 | Jun 10 10:49 PM | ANDREW THOMAS REARDON | Proposed Sale | 500 | $114.54 | $57.3K | — | View → |
| May 15, 2025 | May 15 9:14 PM | ANDREW THOMAS REARDON | Proposed Sale | 1,000 | $104.00 | $104.0K | — | View → |
| Mar 18, 2025 | Mar 18 8:01 PM | Sabba Stephen L | Proposed Sale | 2,406 | $106.00 | $255.0K | — | View → |
| Mar 4, 2025 | Mar 4 10:10 PM | Espinoza Octavio | Proposed Sale | 5,000 | $115.03 | $575.1K | — | View → |
| Dec 23, 2024 | Dec 24 1:19 AM | Espinoza Octavio | Proposed Sale | 2,104 | $116.37 | $244.9K | — | View → |
| Nov 26, 2024 | Nov 27 9:44 PM | LAMATTINA JOHN L | Proposed Sale | 2,406 | $119.19 | $286.8K | — | View → |
| Sep 23, 2024 | Sep 23 9:30 PM | Reardon Andrew | Proposed Sale | 2,000 | $99.60 | $199.2K | — | View → |
| Sep 23, 2024 | Sep 23 9:27 PM | Korenberg Matthew E | Proposed Sale | 14,437 | $101.50 | $1.5M | — | View → |
| Sep 20, 2024 | Sep 20 10:12 PM | Korenberg Matthew E | Proposed Sale | 6,275 | $104.10 | $653.2K | — | View → |
| Sep 20, 2024 | Sep 20 9:39 PM | Espinoza Octavio | Proposed Sale | 1,275 | $103.94 | $132.5K | — | View → |
| Aug 28, 2024 | Aug 28 8:39 PM | Reardon Andrew | Proposed Sale | 1,500 | $106.39 | $159.6K | — | View → |
| Aug 22, 2024 | Aug 22 10:05 PM | Korenberg Matthew E | Proposed Sale | 18,858 | $105.03 | $2.0M | — | View → |
| Nov 11, 2024 | — | Korenberg Matthew E | Proposed Sale | 32,183 | $120.33 | $3.9M | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 31 9:53 PM | John L LamattinaDirector | Option Exercise | 2,161 | $114.15 | 0(D) | View → |
| Mar 2, 2026 | Mar 28 1:20 AM | Octavio EspinozaChief Financial Officer | Grant/Award | 23,527 | $202.55 | 23,527(D) | View → |
| Mar 2, 2026 | Mar 28 12:33 AM | Todd C DavisDirector, Chief Executive Officer | Grant/Award | 50,058 | $202.55 | 50,058(D) | View → |
| Mar 2, 2026 | Mar 28 12:16 AM | Andrew ReardonCLO & Secretary | Grant/Award | 21,525 | $202.55 | 21,525(D) | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,405 | $92.65 | 0(D) | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |
← Previous
Page 2 of 2